Monocrotaline (MCT) and its pyrrole derivative, dehydromonocrotaline (DHMC), interact with molecular targets in cells of the central nervous system. DHMC presents higher toxicity than MCT indicating that its metabolism of MCT is a critical step of this alkaloid toxicity. This study sought to elucidate the metabolism and the toxicity of MCT in C6 astrocyte cell line and primary cultures of rat astrocytes by investigating metabolic enzymatic mechanisms of the cytochrome P450 (CYP) system and conjugation with glutathione. Treatment with omeprazole (OMP) (20 mM), a non-specific inducer of CYP450 induced approximately 10-fold increase in CYP1A1 activity after 2 h of treatment. Similarly, the 7-Ethoxyresorufin-O-deethylase (EROD) activity was induced by treatment with MCT (100e500 mM), indicating that the P450 CYP1A1 isoform was active and involved in the metabolism of MCT. Analysis of conjugation with glutathione showed a significant depletion of GSH after MCT (500 mM) treatment, and this was partially reversed by pretreatment with a P450 inhibitor (cimetidine 100 mM). These results suggest that not only the alkaloid MCT but, also its metabolite may deplete GSH. Rosenfeld staining showed intense vacuolization after MCT treatment, which was partially inhibited in the presence of a P450 activator. MTT test showed that association of MCT with OMP induced a reduction in cell viability in C6 and primary astrocytic cells. These results demonstrate that MCT is metabolized by astrocytic CYP1A1 to generate metabolites that can deplete GSH. Moreover, changes in the activity of the P450 enzymes interfere with the cytotoxic effects induced by the alkaloid.
Introduction
Most of the 600 species of Crotalaria genus (Fabaceae) are toxic to animals. These are found in various regions of the world and present geographical distribution in tropical and subtropical areas (Williams and Molyneux, 1987) .
In Brazil, cases of acute poisoning caused by C. retusa have been reported in sheep (Dantas et al., 2004; Nobre et al., 2005) , cattle (Nobre et al., 2004a) , and equines (Nobre et al., 2004b) , mainly in semi-arid northeastern Brazil. The poisoning is more common in equids, most likely because the plant is more palatable for this species (Riet-Correa and Medeiros, 2001; Riet-Correa et al., 2011) .
The Crotalaria species also garner great interest from agricultural studies, as in green manure and in vegetation cover, but the greatest interest is due to the economic losses caused by livestock poisoning and to exposure of the human population, which uses many of these plants in folk medicine. These plants are rich in pyrrolizidine alkaloids (PA), which are the major toxins derived from these plants that affect humans and animals, and among than, the alkaloid monocrotaline (MCT) is the main toxin (Mattocks, 1986) .
The pyrrolizidine alkaloid MCT is found in plants of the genus Crotalaria sp. It is metabolized in the liver via the microsomal cytochrome P450 system (CYP) (Kasahara et al., 1997) generating three main metabolites: monocrotic acid, retronecine and dehydromonocrotaline (DHMC), also known as monocrotaline pyrrole, the most toxic metabolite. Monocrotaline may also be biotransformed by CYP system generating N-oxides that can in turn be hydrolyzed to 6,7-dihydro-7-hydroxy-1-hydroxymethy-5H-pyrrolizine (DHP), which is also a highly reactive metabolite, or may be converted to dehydroalkaloids (Wang et al., 2005) . In humans, hepatic cytochrome CYP3A4 is involved in both the activation reaction and the detoxication pathway (Miranda et al., 1991) .
In addition to the liver and other organs that are important in the bioactivation of compounds, cells in the brain present an active CYP system to biotransform compounds that cross the blood-brain barrier (BBB) (Dutheil et al., 2008; Hedlund et al., 2001; Orellana and Guajardo, 2004) . Therefore, the slight reactive MCT can be converted into more reactive compounds in target organs as the liver and lungs as well as in the central nervous system (CNS). MCT is primarily hepatotoxic and pneumotoxic, but it (and even its metabolites) can reach other organs, such as the brain. The presence of neurological clinical signs in animals intoxicated with Crotalaria was initially associated with hepatic encephalopathy due to a failure in the urea metabolism, which leads to hyperammonemia (Cheeke, 1988; Nobre et al., 2004b) . Moreover, MCT and its metabolite DHMC were found and measured in the brains of mice that were experimentally intoxicated. These results demonstrated the ability of these molecules to cross the BBB (Yan and Huxtable, 1995) and suggested that the neurological signs observed in intoxicated animals are a result of the efficient metabolism of Crotalaria PA to reactive compounds in CNS cells.
One of the most important functions of astrocytes is to control the presence of neurotoxins within the CNS. They constitute the first line of defense against xenobiotics, expressing high levels of CYP that are approximately 2-fold higher than those found in neurons, indicating that neuronal P450 does not work in the same way that the astrocyte P450 does. Studies of the brain have revealed that bioactivation systems that are dependent on astrocyte-specific CYP monooxygenases play a causal role in the establishment of the brain as the target organ of various toxic agents. The levels of CYP1A, CYP1A1/2, CYP2B1, CYP2B6, CYP2C11, CYP2C, CYP2D6, CYP2E1 and CYP3A were determined in rats and in human astrocytes, and these enzymes were considered to be functionally active (for review, see Malaplate-Armand et al., 2004; Meyer et al., 2001) .
Thiols like L-cysteine can prevent the cytotoxicity induced by some alkaloids such as apomorphine (El-Bacha and Minn, 1999) . Reduced glutathione (GSH) is an endogenous peptide containing cysteine that is conjugated to xenobiotics by glutathione S-transferases (EC 2.5.1.18) in an attempt to neutralize them. An important function of astrocytes is the predominant source of GSH in the CNS. A compromised GSH system in the brain has been associated with the oxidative stress occurring in neurological diseases. In this respect, astrocytes appear to play a key role in the GSH metabolism of the brain, since astroglial GSH export is essential for providing GSH precursors to neurons and astrocyte-derived GSH plays important roles in protecting neurons from oxidative stress (Dringen and Hirrlinger, 2003) . The dehydromonocrotaline appears to be neutralized by conjugation with glutathione (GSH) (Pitanga et al., 2011) . Astrocyte GSH levels are influenced by cytokine signaling pathways with regulate specific aspects of astrogliosis (Hamby and Sofroniew, 2010) .
In previous studies, we determined that the molecular targets of MCT and DHMC include DNA and specific cytoskeletal proteins, such as glial fibrillary acidic protein (GFAP), specific of astrocytes and b-III tubulin, specific of neurons, and others cytoskeletal proteins as mitogen activated protein kinases (MAP) and vimentin. Futhermore, astrocyte metabolism plays a pivotal role in metabolism in MCT-induced neurotoxicity (Barreto et al., 2006 (Barreto et al., , 2008 Silva-Neto et al., 2010; Pitanga et al., 2011; revised in Pitanga et al., 2012) . Thus, the present study was developed using the C6 astrocytic cell line and the primary culture of glial cells as in vitro model to better understand the mechanisms involved in the metabolism and the toxicity of MCT and its biotransformation by CNS cells; in particular, the role of CYP enzymatic complex and the conjugation with GSH.
Materials and methods

Cell culture
C6 cells derived from rat glioma (Geng and Strobel, 1995 were used between 20 passages, maintained in a humidified atmosphere with 95% air and 5% CO 2 at 37 C in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal bovine serum (FBS) (GIBCO BRL, Grand Island, NY), a nutrient mixture (7 mM glucose, 2 mM glutamine, 0.011 g/l pyruvate) and antibiotics (100 IU/mL penicillin G, 100 mg/mL streptomycin). Cells were grown on 100 mm diameter tissue culture plates (TTP, Switzerland) containing 10 mL of medium, which was replaced three times a week. Upon reaching confluence, the cells were trypsinized and were subcultured on other plates (96-, 24-or 6-well plates) based on the analytical procedures to be performed, at a density of 3.1 Â 10 4 cells/cm 2 and cultured for more 1 day.
Astrocyte primary cultures were prepared according to Cookson and Pentreath (1994) . Briefly, cerebral hemispheres from one-dayold postnatal Wistar rat pups were isolated aseptically, and meninges were removed. The cortex was dissected out and then gently forced through a sterile 75-m Nitex mesh. Cells were suspended in DMEM HAM F12 medium (Cultilab, SP, Brazil), supplemented with 100 IU/mL penicillin G, 100 mg/ml streptomycin, 2 mM L-glutamine, 0.011 g/l pyruvate, 10% FCS, 3.6 g/L Hepes and 12 mM glucose (Cultilab, SP, Brazil) and cultured in dishes with 10 cm in diameter in a humidified atmosphere with 5% CO 2 at 37 C. Culture medium was changed every two days, and the cells were cultured for 15 days. Then, the cells were trypsinized and subcultured in other plates (96-, 24-or 6-well plates) according to the analytical procedures to be performed, at a density of 3.1 Â 10 4 cells/cm 2 and cultured for more 2 days. All experimental procedures were performed in agreement with the Animal Care and Use Committee of the Instituto de Ciências da Saúde, Universidade Federal da Bahia -CEUA (Registration No. 027/2012).
Drugs and treatment
MCT was extracted and purified from an aqueous extract of C. retusa seeds using the Culvenor and Smith method (1957) as previously described (Barreto et al., 2006 (Barreto et al., , 2008 , except that hexane was used instead of petroleum ether and possible N-oxide forms were not converted into free bases. The characterization of the MCT was performed using 13C and 1H nuclear magnetic resonance and infrared spectrum. For stock solutions of MCT (100 mM) was dissolved in dimethylsulfoxide (DMSO, Sigma, St. Louis, MO) and stored at À20 C. Cells were treated with concentrations ranging from 100 to 500 mM MCT for 24 h and 72 h. The negative control group was treated with only with 0.1% DMSO diluted in the culture medium and showed no significant effect on analyzed parameters compared to cells that did not receive diluents. Cimetidine (CIM) was obtained from Sigma-Aldrich (Sigma C4522). It is a potent CYP inhibitor complex (Shaik and Mehvar, 2010; Chang et al., 1992) that acts on various isoforms of this enzyme complex. It was dissolved in distilled water to make 10 mM-stock solutions and stored at À20 C. The cells were treated with 100 mM CIM, 40 min before the MCT treatment. Omeprazole (OMP) was obtained from Sigma-Aldrich (Sigma 73590-58-6). It is an inducer of CYP1A and 2C19 families (Shivanna et al., 2011 DRUG DATABASE, 2013 . It was dissolved in distilled water to make a 500 mM stock solution and stored in the dark at À20 C. The cells were treated with 20 mM of OMP in association with MCT.
CYP-catalyzed O-dealkylation assay and protein determination
CYP1A1 or CYP1A2 activity was determined by measuring the formation rate of resorufin from ethoxyresorufin or methoxyresorufin, respectively, using a modification of the procedure described by Burke and Mayer, 1974 . Cells treated with 0.1% DMSO, 20 mM OMP or MCT (100e500 mM) were incubated with 1 mM ethoxyresorufin or methoxyresorufin in order to investigate the CYP O-dealkylase activity for 2 h at 37 C. Then, 200 mL of medium was removed from each plate and transferred to a 96-well blackplates to measure the fluorescence using at 586 nm after excitation at 510 nm CYP1A activity was expressed as the amount in pmoles of resorufin formed per min per mg protein. Following the determination of ethoxyresorufin-O-dealkylation (EROD) or methoxyresorufin-O-dealkylation (MROD) activity, the residual medium was removed, cells were washed twice with PBS, then scraped into 1.5 mL of fresh PBS. Cells were lysed in 2% (w/v) SDS, 2 mmol/L EGTA, 4 mol/L urea, 0.5% (v/v) Triton X-100, and 62.5 mmol/L Tris-HCl buffer (pH 6.8) supplemented with 0.1% (v/v) of a cocktail of protease inhibitors (Sigma). Protein content was determined using a method adapted from Lowry et al. (1951) with a DC protein assay reagent kit (Bio-Rad, Hercules, CA, USA). Three independent experiments were performed with eight replicate wells for each analysis.
Evaluation of reduced glutathione depletion
Monochlorobimane (MCB) was used to evaluate GSH depletion in astrocyte primary cultures. A stock solution of MCB was prepared at 100 mM in absolute ethanol and stored at À20 C in the dark. DLbuthionine-SR-sulfoximine (BSO) was used at a concentration of 1 mM to inhibit GSH synthesis, and this was adopted as the positive control. Moreover, 40 min before the MCT treatment, CIM (100 mM), a known inhibitor of many CYP isozymes, was added to the cultures. After a 72-h treatment with 500 mM MCT, cultures were washed three times with PBS, and incubated with 1 mM MCB in 400 mL of the culture medium for 40 min. Thereafter, cells were washed again with PBS. Cells were observed by fluorescence microscopy (Olympus BX 51-URA2). The fluorescence mirror unity Olympus U-MWU2 was selected to observe cells. This mirror unity excites the fluorochrome in the band between 330 and 385 nm; it has a dichromatic mirror (400 nm) and an emission filter of 420 nm. Photographs were taken using an exposure time of 60 ms for all samples by an Olympus BX-2 camera attached to the microscope. Three independent experiments were performed with three replicate wells for each analysis.
Cell viability
Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma, St. Louis, MO) test. The experiment was performed on 96-well plates (TPP Switzerland) with C6 cell or astrocyte primary cultures. The cells were incubated with MCT (500 mM) and/or OMP (20 mM) for 72 h.
The cell viability was quantified using the conversion of yellow MTT by mitochondrial dehydrogenases of living cells to purple MTT formazan as an index (Hansen et al., 1989) . Control and treated cells were incubated with MTT at a final concentration of 1 mg/mL for 2 h. Thereafter, the cells were lysed with 20% (w/v) sodium dodecyl sulfate (SDS) in 50% (v/v) dimethylformamide (DMF) (pH 4.7). Plates were incubated overnight at 37 C to dissolve formazan crystals. The optical density of each sample was measured at 492 nm using a spectrophotometer (Thermo Plate-Reader). Three independent experiments were performed with eight replicate wells for each analysis. The results from the MTT test are expressed as percentages of the viability of the treated groups related the control groups.
Morphological changes
Morphological changes and vacuolization were primarily assessed based on an analysis of Rosenfeld's staining. The experiment was performed on plates with 3.5 cm in diameter (TPP Switzerland). After 72 h of exposure to MCT (500 mM) and/or OMP (20 mM), the cells were rinsed three times with PBS (without Ca 2þ and Mg 2þ ) and fixed for 10 min with methanol at À20 C. The fixed cells were stained. Rosenfeld's reagent (1 ml) was added and incubated for 20 min at room temperature. Thereafter, the plates were rinsed with water, air-dried, analyzed using an optic microscope (Olympus BX70) and photographed using a digital camera (CE Roper Scientific). Vacuolation was quantified in ten fields. Astrocytes on primary culture or C6 cells with more than 10 vacuoles in the cytoplasm were considered to be vacuole-possessing astrocytes (Isobe et al., 2003; Silva et al., 2013) .
Statistical analysis
Each experimental variable was analyzed in three independent experiments and the results were expressed as the mean ± standard deviation. One-way ANOVA followed by the Student-NewmannKeuls test was used to determine the significant differences among the groups differing in only one parameter.
Results
MCT activates CYP1A1
Experiments to evaluate the MCT metabolism via the CYP1A family were performed using the enzyme substrates ethoxyresorufin and methoxyresorufin, which are specific for 1A1 and 1A2 isoforms, respectively, 2 h and 12 h after treatment of C6 cells (Fig. 1AeD) . Treatment with OMP (20 mM), a non-specific inducer of CYP enzymes induced significant increase of approximately 10-fold in CYP1A1 activity after 2 h of treatment compared with the control (0.5% DMSO) (Fig. 1A) . Similarly, the EROD activity was induced by treatment with MCT at concentrations of 100, 200 and 500 mM, indicating that the CYP1A1 isoform was induced by MCT (Fig. 1A) .
Treatment with OMP (20 mM) also induced a significant increase of approximately 3-fold in CYP1A2 activity after 2 h treatment compared with the negative control (0.5% DMSO) (Fig. 1B) . However, there was no significant change in CYP1A2 activity after treatment with MCT (100, 200 and 500 mM) (Fig. 1B) .
Although the EROD activity did not change 24 h after treatment with 500 mM MCT or 20 mM OMP a significant increase was observed in cells treated with both drugs (Fig. 1C) . This suggests that the CYP1A1 induction decreased 24 h after treatment. Concerning experiments to investigate the MROD activities, neither MCT, nor OMP increased CYP 1A2 activity 24 h after treatments (Fig. 1D) .
Monocrotaline induces GSH depletion
The use of MCB to assess GSH depletion showed that BSO induced a total depletion, but 500 mM MCT induced only a partial depletion (Fig. 2) . However, this partial depletion was reverted by 100 mM cimetidine (CIM), which is a potent CYP inhibitor. This suggests that a MCT metabolite was responsible for this effect rather than MCT itself.
MCT treatment induces cytoplasmic vacuolation which are suppressed by the CYP inducer OMP
Morphological changes in astrocytic cultures were investigated by staining of the cells with the panchromatic Rosenfeld's dye (Fig. 3 and Fig. 4) . In control conditions, the C6 cells (0.5% DMSO) exhibited a typical fusiform morphology (Fig. 3 A) . However, after 72 h of treatment with the alkaloid MCT (500 mM), OMP (20 mM) or a combination of the two (20 mM OMP þ 500 mM MCT), the cells showed intense vacuolization and stretching and/or thickening of the cell extensions (Fig. 3 A) . The quantification of cells with more than ten cytoplasmic vacuoles, revealed that the MCT alone or associated with OMP induced a 10-fold and 8-fold increase in the number of cells undergoing the of vacuolization process, respectively (Fig. 3 B) , compared with control cultures (0.5% DMSO).
In the control primary cultures, the predominance of polygonal astrocytes (Fig. 4) was verified, and few cells with contracted cytoplasm, more electrodense cell body, and multiple branches were observed. An increase in the proportion of cells with contracted cytoplasm and multiple branches was evidenced in primary cultures of astrocytes after treatment with MCT (500 mM) (Fig. 4 A) , which was amplified dramatically in cultures with MCT associated with OMP (20 mM). Under these conditions, the cells presented a phenotypes, with retracted cytoplasm with multiple branches which formed a net of interacting cells (Fig. 4 A) , performing an interaction through their prolongment. The quantification of astrocytes with more than ten cytoplasmic vacuoles revealed that the MCT alone induced an increase in the number of cells undergoing the process of vacuolization, that was amplified by associated treatment with OMP (Fig. 4 B) , when compared with control cultures (0.5% DMSO).
Cytotoxicity induced by MCT associated with OMP
The effect of MCT and its association with the CYP inhibitor (CIM) or inducer (OMP) on the cell viability of astrocytic C6 cells and glial primary cultures was determined by measuring the function of mitochondrial dehydrogenases (MTT assay) after 72 h. No changes in cell viability were observed in cultures treated with 20 mM OMP, 500 mM MCT or 100 mM compared to control cultures (0.5% DMSO) (Fig. 5AeB) . However, this test showed that exposure to MCT associated with OMP (20 mM) induced a significant reduction in cell viability in approximately 19e25%.
Discussion
Glial cells, especially astrocytes, are crucial for the control of homeostasis in the CNS, for providing nutritional and structural support for neurons and for participating in other functions, such as immune functions, metabolism and detoxification via the CYP system (Tardy, 1991; Montgomery, 1994; Kandel, 2000) . In this regard, astrocytic C6 cells have been used to study the involvement of the CYP enzymatic system in neural cells Strobel, 1993, 1997) due to the efficient expression of this system in this cell strain (Strobel et al., 1995) . In this study, we investigated whether glial toxicity of the alkaloid MCT is related to modulation of CYP isoforms using specific substrates of the CYP1A family, an inhibitor, and an inducer of this enzyme complex (Chang et al., 1992; Lin and Lu, 1998; Angiolillo et al., 2011) . We focused our investigation in isoforms CYP1A 1/2, considering that the expression of these isoforms have been shown to be distributed in some areas of the brain (striatum, hypothalamus). CYP1A1/2 has long be associated to metabolize compounds such as caffeine, aflatoxin-B, heterocyclic arylamines, and plays an important role in the protection of neurons from potentially toxic compounds (Riedl et al., 1996) . Treatments with MCT between 100 and 500 mM induced the EROD activity after 2 h, like OMP, a CYP inducer. However, this effect decreased after 24 h. Differences in the inducibility of CYPA1 in mice can influence the development of tumors (Guengerich, 1992) .
In this study, Rosenfeld staining showed the presence of vacuolization C6 and astrocytes treated with the alkaloid MCT (500 mM) had a 10-fold increase in this process compared with the control condition (0.5% DMSO). Interestingly, Pitanga et al. (2011) showed vacuolization in neuron/glia co-cultures when they were treated with the alkaloid MCT (100 mM). In addition, vacuolation was verified by Santos et al. (2008) through the hepatic histology of horses and ruminants that were accidentally fed hepatotoxic plants (Panicum spp., Tribulus terrestris, Lechiguilla agave and Nathercium ossifragum), suggesting a hyperplasia of smooth cytoplasmic reticulum as a function of drug detoxification.
Studies indicate that GSH protects against oxidative stress, and glial GSH depletion causes several biochemical and molecular changes that might be toxic to neurons and be related to neurological disorders (Lee et al., 2010) . In a previous study, it was observed that treatment with100 mM MCT depleted GSH in cocultures of astrocytes/neurons and that the GSH depletion was reversed when the cytochrome P450 enzymatic system was inhibited by CIM (Pitanga et al., 2011 (Pitanga et al., , 2012 . In addition, it was demonstrated that neurons exposed to MCT in a co-culture system present interruptions on b-tubulin III expression. These findings indicate that GSH depletion is dependent on the metabolism and synthesis of active metabolites via the P450 system and that this phenomenon is involved in MCT-induced neurotoxicity. Since glial cells are responsible for maintaining CNS homeostasis and protecting neurons from toxic damage, the present study contributes to the understanding of the role of glial cells in the metabolism of MCT and related neurotoxicity.
The use of omeprazole (OMP) as inducers of metabolism in liver cells, in particular of CYP, has already been well described (Diaz et al., 1990; Couroucli et al., 2002) . In this study, we used OMP as a CYP inducer in astrocytic cells. Astrocytes in primary culture treated with MCT in association with OMP exhibited more cytoplasmic vacuolation than those treated with MCT alone. It is known that macroautophagy could be confused with other types of cytoplasmic vacuolization. Autolysosomes, which could be observed under light microscopy, are not true vacuoles that sometimes expand to fill the cytoplasm and are therefore often referred to as autophagic vacuoles (Aki et al., 2012) . Macroautophagy is a protective process against cellular death that eliminates molecules or damaged organelles and could induce apoptosis (Paris et al., 2011) . Interestingly, the association of MCT with a CYP inducer (OMP) induces cytotoxicity based on the MTT test, but MCT alone did not have this effect. These results suggest an involvement of cytoplasmic vacuolation in the protective mechanism against MCT. More studies are needed to characterize the types of cytoplasmic analyzed by microscopy after treatment with MCT (500 mM), with the association of MCT (500 mM) and CIM (100 mM), an inhibitor of CYP, or with the vehicle DMSO (0.5%). Buthionine sulfoximine (BSO, 1 mM), a potent inhibitor of the enzyme gamma-glutamyl-cysteine synthetase, was used to deplete cellular GSH and adopted as positive control. Obje. 20 Â 0.70. vacuolization induced by MCT.
In addition, an association of MCT with the CYP inducer OMP also induced astrocytes to acquire bipolar phenotype generating areas that was otherwise restricted to cells with a very stellate branched phenotype. Changes in the phenotype of glial cells, typically astrocytes and microglia, characterize reactivity and are associated with toxic insults as observed after exposure to MCT in our previous studies (Barreto et al., 2008; Pitanga et al., 2011 Pitanga et al., , 2012 .
The P450 system (CYP) is an enzymatic complex that is used as a xenobiotic metabolism pathway. The total CYP levels in the brain are low, approximately 0.5e2% of those in the liver, and it is unlikely that the CYP-mediated metabolism in the brain substantially influences the systemic levels of metabolites (Hedlund et al., 2001) ; however, the location of CYP in specific brain regions and in cell types allows a considerable impact on the metabolism of certain changes in microenvironments in the brain and in the brain as a whole (Miksys et al., 2002) . In our study, we used two specific substrates for the CYP family 1A, ethoxyresorufin and methoxyresorufin, which are specific to the CYP1A1 and CYP1A2 subfamilies, respectively, in cultures treated with MCT and/or cimetidine and omeprazole. These substrates, when in contact with cellular machinery, could be converted to the fluorescent product resorufin, which would be released in the culture medium, demonstrating the involvement or lack thereof of these families in MCT metabolism. It is known that the CYP3A4 family (Couet et al., 1996; Kasahara et al., 1997) metabolizes MCT in the liver. In this study, we investigated the involvement of CYP1 because astrocytic cells express many isoforms of CYP1A (Ferguson and Tyndale, 2011) and the fact that our in vitro glia cell culture and neuron/glia co-culture models use Wistar strain rat cells (Pitanga et al., 2011) . Our results showed increased conversion of ethoxyresorufin to resorufin only in cultures treated with both MCT and OMP, indicating the activation of CYP1A1, which may be related to the toxicity observed for MTT in this condition.
As discussed above, to be toxic, the alkaloid MCT needs to be metabolized by CYP, which in turn generates active metabolites (DHMC) that are capable of causing toxicity to cells. In turn, these metabolites can be conjugated with glutathione following the route of detoxification. In this study, we used monochlorobimane (MCB) to assess the depletion of GSH. We observed that exposure to both MCT (500 mM) and BSO (positive control) depletes GSH in astrocytic cells, based on a reduction in fluorescence. However, it is important to note that the depletion of GSH by MCT was partial. Interestingly, the inhibition of the CYP enzyme system by pre-treatment with CIM inhibited GSH depletion. Cimetidine is a known H2 histamine receptor antagonist, which also has an effect as a potent inhibitor complex CYP (Chang et al., 1992; Shaik and Mehvar, 2010) that acts on various isoforms of this enzyme complex (Messiah, 2004) . However, it not may be excluded that other mechanisms than CYP inhibition could be proposed to explain the partial inhibition of the GSH depletion induced by MCT using CIM, considering that CIM pretreatment, also known as an inhibitor of the organic cation transport systems, might affect the uptake of MCT within the cells, resulting in different response to this compound (Ito et al., 2012) .
Interestingly, Pitanga et al. (2011) showed that MCT (100 mM) is capable of inducing the full depletion of GSH in glia/neuron cocultures from 12 h after treatment. This shows that isolated astrocytic cells are able to perform phase II metabolism alone. In a study conducted by Lee et al. (2010) , it was demonstrated that glial cells containing GSH protect against oxidative stress and that GSH depletion is associated with various molecular changes that can be related to neurological disorders. Thus, this study and those performed by Baker et al. (1990) and Silva-Neto et al. (2010) suggest that the lack of cytotoxicity observed in glial cells may be due to an efficient protection through conjugation with GSH toxic metabolites.
In conclusion, the results of the present study demonstrate that monocrotaline is metabolized by astrocytic CYP1A1 to generate metabolites that can deplete GSH. Furthermore, changes in the activity of P450 enzymes interfere on monocrotaline cytotoxic effects. MCT combined with OMP. Values for vehicle control samples (0.5% DMSO) were set at 100%; *P < 0.05 compared with control.
